Evidence map›Paper›PMID 41639668›Full record

ReviewMolecular neurodegeneration2026

Lipid alterations in hereditary peripheral neuropathies: common mechanisms in disease heterogeneity?

Koen Kuipers, Sam Vanherle, Kirsten Poelmans, Esther Wolfs, Jeroen Bogie, Tim Vangansewinkel

Abstract readReview
In one paragraph

Review in Molecular neurodegeneration, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Koen KuipersDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Sam VanherleDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Kirsten PoelmansDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Esther WolfsLab for Functional Imaging & Research on Stem Cells (FIERCELab), Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Jeroen BogieDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Tim VangansewinkelLab for Functional Imaging & Research on Stem Cells (FIERCELab), Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium. tim.vangansewinkel@uhasselt.be.

Funding

Charcot Research Foundation CHARCO23BJFonds voor Wetenschappelijk Onderzoek (FWO-Vlaanderen) 1104425NFonds voor Wetenschappelijk Onderzoek (FWO-Vlaanderen) 11PLR24NFWO Vlaanderen G075823FWO-Vlaanderen fundamental research postdoc program 1246724NFWO-Vlaanderen fundamental research postdoc program 12Z2620NGeneeskundige Stichting Koningin Elisabeth GSKE-BOGJMS Liga Vlaanderen MSLIGABOGJUHasselt BOF 22DOC38BOFUHasselt BOF R-14084VLIR iBOF/23/021
6 · The paper itself

Abstract

While the impact of lipid alterations on central nervous system disorders is well-studied, increasing evidence indicates that lipids also play an important role in the pathology of hereditary peripheral neuropathies (HPN). It is becoming clear that Schwann cells and neurons in peripheral nerves heavily depend on lipids for membrane interactions, (sub)cellular signalling, and the formation of myelin sheaths. In support of this notion, disturbances in the level and composition of lipid classes, including phospholipids, sphingolipids and cholesterol, perturb normal functioning of peripheral nerves. Intriguingly, lipid disturbances seem to be a common denominator within the heterogeneous group of HPN, with hindrances in cholesterol and sphingolipid metabolism primarily influencing Schwann cell and neuron homeostasis, respectively. In this review, we provide an overview of lipid disturbances in various HPN with the goal of finding main commonalities between the different diseases and to identify potential novel treatment strategies.

Indexed as

Lipid MetabolismPeripheral Nervous System DiseasesAnimalsHumansMyelin SheathNeuronsSchwann CellsDemyelinationLipid metabolismNeurodegenerationNeuronsPeripheral neuropathySchwann cells

Identifiers

PMID41639668
PMCPMC12964804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.